Screener
Sarepta Therapeutics, Inc. SRPT Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s total assets?
- Sarepta Therapeutics, Inc. (SRPT) reported total assets of $3.19B in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s total assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s total assets decreased by 13.4% year-over-year, from $3.68B to $3.19B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total assets has grown at a 2.3% compound annual growth rate (CAGR), from $2.98B to $3.35B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Sarepta Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude